Avacta Group Plc (LON:AVCT - Get Free Report)'s share price rose 11.6% on Thursday . The company traded as high as GBX 39 ($0.52) and last traded at GBX 38.99 ($0.52). Approximately 5,274,668 shares traded hands during mid-day trading, an increase of 183% from the average daily volume of 1,863,729 shares. The stock had previously closed at GBX 34.95 ($0.47).
Avacta Group Price Performance
The stock has a 50-day moving average price of GBX 32.94 and a two-hundred day moving average price of GBX 37.57. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53. The stock has a market cap of £181.22 million, a price-to-earnings ratio of -6.14 and a beta of 1.12.
Avacta Group (LON:AVCT - Get Free Report) last released its earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.11)) earnings per share (EPS) for the quarter. Avacta Group had a negative net margin of 114.45% and a negative return on equity of 74.00%. As a group, equities research analysts forecast that Avacta Group Plc will post -9.9011833 EPS for the current year.
Avacta Group Company Profile
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
Featured Stories
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access